Slowing Noted in Growth of Cancer Expenditures

This article originally appeared here.
Share this content:
Slowing Noted in Growth of Cancer Expenditures
Slowing Noted in Growth of Cancer Expenditures

THURSDAY, Jan. 21, 2016 (HealthDay News) -- From 1998 to 2012, cancer care expenditures increased at an annualized rate of 2.9 percent, although the growth slowed from 2007, according to a study published online Jan. 15 in Cancer.

James A. Lee, from the Altarum Institute in Ann Arbor, Mich., and colleagues examined trends in spending on cancer from 1998 through 2012. They used condition-specific distribution of expenditures from the Medical Expenditure Panel Survey together with data from the National Nursing Home Survey and other sources to allocate the Personal Health Care components of the National Health Expenditure Accounts.

The researchers found that from 1998 to 2012, cancer care expenditures increased at an annualized rate of 2.9 percent. During 2007 to 2009, the share of expenditures for hospital-based care dropped to a low of 48 percent. Between 2007 to 2009 and 2010 to 2012, there was a substantial decline in professional and clinical services' shares as the hospital share increased. For all payers, the treated prevalence decreased between the first and last study periods, with the exception of an 11.2 percent increase for private payers. Out-of-pocket expenditures decreased to 4.7 percent, while there was a slight increase in Medicare's share. There was an increase in medication expenditures, notably within mail order and retail settings.

"The previous rapid growth of cancer prevalence and expenditures has now slowed, most remarkably since the 2007 recession," the authors write.

The study was supported by the Pharmaceutical Research and Manufacturers of America.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Critics Demand Stop to 'Guinea Pig' Sepsis Clinical Trial

Critics Demand Stop to 'Guinea Pig' Sepsis Clinical ...

Clovers trial seeks to determine which IV fluids, vasopressors combo works best to curb sepsis

Education Can Up Emotional Intelligence in Residents

Education Can Up Emotional Intelligence in Residents

Increase in total EI median scores, stress management composite score after intervention

Cancer-Related Gene Variations Frequently Reclassified

Cancer-Related Gene Variations Frequently Reclassified

24.9 percent of variants of uncertain significance were reclassified at a single commercial laboratory

is free, fast, and customized just for you!




Already a member?

Sign In Now »